ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2026

Abstract Number: 1769

Understanding the Impact of Systemic Lupus Erythematosus on Work Productivity and Daily Activity Among African American Women

Chelsea Ezeako1, Bethany Wolf2, Taylor White1, Lori Ann Ueberroth3, L Quinnette King3, Charmayne Dunlop-Thomas4, Lee Moultrie5, Marquetta Goodwine6, Edith Williams7, S. Sam Lim8, Carl Langefeld9, Diane Kamen10 and Paula Ramos1

Affiliations: 1Emory University School of Medicine, Atlanta, GA, 2Medical University of South Carolina, Charleston, SC, 3Medical University of South Carolina, Charleston, 4Emory University, Atlanta, GA, 5Lee H Moultrie & Associates, North Charleston, 6Gullah/Geechee Nation, St Helena Island, SC, 7University of Rochester Medical Center, Rochester, NY, 8Department of Medicine, Division of Rheumatology, Emory University School of Medicine, Atlanta, GA, 9Wake Forest University School of Medicine, Winston Salem, NC, 10Medical University of South Carolina, Johns Island, SC

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2026

Keywords: functional status, Minority Health, Systemic lupus erythematosus (SLE), Women's health, work

Session Information

Date: Monday, November 9, 2026

Title: (1735-1769) Epidemiology & Public Health Poster B

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose:

Systemic lupus erythematosus (SLE) causes a range of fluctuating symptoms affecting individuals and their ability to work. African American women experience a disproportionate burden of SLE, which can significantly affect daily functioning. Yet few studies have directly examined how SLE shapes work productivity and activity in this population. This study evaluated the association between SLE and self-reported productivity and activity impairment among African American women.

Methods: Cross-sectional data were collected from 256 self-reported African American women with and without SLE. SLE diagnosis was confirmed using ACR/EULAR 2019 classification criteria. Among participants with SLE, disease activity was measured using the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) and cumulative organ and functional damage using the Brief Index of Lupus Damage (BILD). Participants self-reported the impact of their illness on work productivity and daily activity over the past 6 months using a visual analog scale (VAS; 0-100), where higher scores reflect greater impairment. Productivity was defined as illness-related limitations in the amount, type, or quality of work performed. Activity encompassed regular daily activities, at home and/or work, such as household work, shopping, exercise, studying, etc. Associations between SLE status and VAS scores were assessed using Wilcoxon rank sum tests; Spearman rank correlations examined associations with age, disease duration, SLEDAI, and BILD. All analyses were conducted in R v.4.3.2.

Results: Of 256 participants (mean age 46.4 ± 12.6 years), 142 (55.5%) had SLE. Participants with SLE reported dramatically higher productivity impairment (median VAS 50, IQR: 10.75-75.25) compared to those without SLE (median 2, IQR: 0-16.25; P < 0.001). Activity impairment followed the same pattern, with SLE participants reporting a median score of 50 (IQR: 19-68.5) versus 2.5 (IQR: 0-23.5) in those without SLE (P < 0.001). Participant age was not associated with either outcome. Among those with SLE, mean disease duration was 15.7 ± 8.9 years, median SLEDAI was 2 (IQR: 0-4), and median BILD was 2 (IQR: 1-4). Accumulated organ damage (BILD) was weakly correlated with productivity impairment (ρ = 0.16, P = 0.065), while disease duration and current disease activity (SLEDAI) were not significantly correlated with either productivity or activity scores (0.21 < P < 0.96).

Conclusion: SLE is strongly associated with impaired work productivity and daily activity among African American women. Because this substantial functional burden is not explained by current disease activity and disease duration, the trend associating higher organ damage with productivity loss warrants further longitudinal investigation. These findings highlight the need to routinely evaluate and address productivity and functional limitations as part of comprehensive, individualized care in this population.


Disclosures: C. Ezeako: None; B. Wolf: None; T. White: None; L. Ueberroth: None; L. King: None; C. Dunlop-Thomas: None; L. Moultrie: None; M. Goodwine: None; E. Williams: None; S. Lim: AstraZeneca, 12,, 12, , Biogen, 12,, BMS, 12,, 12, , EMD Serono, 12,, Gilead, 12,, GSK, 12,, 12, , Novartis, 12,, Roche/Genentech, 12,, UCB, 12,; C. Langefeld: None; D. Kamen: None; P. Ramos: None.

To cite this abstract in AMA style:

Ezeako C, Wolf B, White T, Ueberroth L, King L, Dunlop-Thomas C, Moultrie L, Goodwine M, Williams E, Lim S, Langefeld C, Kamen D, Ramos P. Understanding the Impact of Systemic Lupus Erythematosus on Work Productivity and Daily Activity Among African American Women [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9). https://acrabstracts.org/abstract/understanding-the-impact-of-systemic-lupus-erythematosus-on-work-productivity-and-daily-activity-among-african-american-women/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/understanding-the-impact-of-systemic-lupus-erythematosus-on-work-productivity-and-daily-activity-among-african-american-women/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology